LONDON--(BUSINESS WIRE)--Regulatory News: BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, today ...
Toulouse, France, November 7, 2013 - Genticel, a biopharmaceutical company that develops innovative vaccines for patients infected with the human papillomavirus (HPV), has appointed a new ...
JERUSALEM — The board of directors of The Joshua Fund today announced the appointment of Dr. Carl A. Moeller as the organization’s new executive director, effective June 1, 2020. Dr. Moeller was ...
BenevolentAI CEO Dr Joerg Moeller tells Proactive's Stephen Gunnion how the company is positioning itself as a pioneer in AI-augmented drug discovery, aiming to enhance the success rates of drug ...
PAUL MOLLER is Chairman of the Board of Moller International Inc. In 1972 Dr. Moller founded Supertrapp Industries and was Chief Executive Officer as Supertrapp became the most recognized ...
LYON, France--(BUSINESS WIRE)--POXEL SA (Euronext: POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 ...
Moller Industries, the brainchild of inventor Dr. Paul Moller, announced recently that production would begin on the company's M200G volantor, a UFO-esque hovercraft that apparently can "glide over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results